Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.

Autor: Elwazir M; Department of Cardiology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota., Krause ML; Division of Rheumatology, Department of Medicine, University of Kansas, Kansas City, Kansas., Bois JP; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota., Christopoulos G; Department of Medicine, Mayo Clinic, Rochester, Minnesota., Kendi AT; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Cooper JLT; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida., Jouni H; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota., Abouezzeddine OF; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota., Chareonthaitawee P; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: Chareonthaitawee.panithaya@mayo.edu., Abdelshafee M; Department of Cardiology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt., Amin S; Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota; Division of Epidemiology, Department of Health Sciences Research, Rochester, Minnesota.

Publikováno v: Journal of cardiac failure [J Card Fail] 2022 Feb; Vol. 28 (2), pp. 247-258. Date of Electronic Publication: 2021 Jul 25.